Drug intelligence / Profile preview

Tempophore

Development stage: Unknown
Modality: Small Molecules
Administration: Intracanal

Overview

Tempophore is a dental product used primarily for the treatment of non-vital deciduous root canals and for the treatment and obturation of infected canals in temporary teeth. It is radiopaque, making it suitable for short and long-term follow-up. The search results indicate that Tempophore is used in pediatric dentistry, specifically for pulp therapy in primary dentition. In one clinical study, Tempophore showed a high success rate of 95.6% when used as a pulpotomy agent in primary teeth.

Brand names: Tempophore
Other names: formocresol

Beyond the preview

Go deeper on Tempophore.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tempophore.

Explore the full profile